Detailed Information on Publication Record
2010
Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy
BELADA, David, L. SMOLEJ, P. STEPANKOVA, P. KRALICKOVA, Tomáš FREIBERGER et. al.Basic information
Original name
Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy
Authors
BELADA, David (203 Czech Republic), L. SMOLEJ (203 Czech Republic), P. STEPANKOVA (203 Czech Republic), P. KRALICKOVA (203 Czech Republic) and Tomáš FREIBERGER (203 Czech Republic, guarantor, belonging to the institution)
Edition
LEUKEMIA RESEARCH, Belada D Smolej, 2010, 0145-2126
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.555
RIV identification code
RIV/00216224:14110/10:00046815
Organization unit
Faculty of Medicine
UT WoS
000280576500029
Keywords in English
HYPERIMMUNOGLOBULINEMIA-E; HODGKIN LYMPHOMA; JOBS-SYNDROME; MUTATIONS
Změněno: 16/1/2011 00:35, prof. MUDr. Tomáš Freiberger, Ph.D.
Abstract
V originále
A case of patient with hyper-IgE syndrome and diffuse large B-cell lymphoma who achieved a durable remission after modified immunochemotherapy is rported. Heterozygous point mutation (c.1259A > C) in codon 340 of the DNA-binding domain of STAT3 was detected in the patient .